Pharmaxis Ltd (pxs) Logo

Pharmaxis Ltd (PXS)

___:___ · Healthcare
ASX Delayed
Cboe unavailable

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

PXS ASX Chart

Snapshot

Pharmaxis Limited (PXS) is involved in the research, development and commercialization of healthcare products for fibrotic (including some cancers) and inflammatory diseases. The company has a highly productive drug discovery engine, drug candidates in clinical trials and two respiratory products approved in global markets generating ongoing revenue.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -60.08%
vs ASX 200 (1yr) -68.46%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,537 of 2,380
Sector Rank 145 of 223

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies NOX / AT1 / LTP
EPS $0.00
DPS $0.00
Book Value Per Share $0.00

Broker Consensus

Please see the Broker Consensus page.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Frenchs Forest NSW 2086
Website www.pharmaxis.com.au
Registry Computershare
Auditor PricewaterhouseCoopers
Date Listed 10 Nov 2003

Upcoming Calendar (Forecasted)

Date Event
09/02/2024 Report (Interim)
26/08/2024 Report (Prelim)
24/10/2024 Report (Annual)

Former Company Names

  • Pharmaxis Limited PXS (11/11/2003)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

PXS directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
02/12/22 Niel Graham Issued 3,000,000 $0.063 $189,000 Issue of options
02/12/22 Malcolm McComas Issued 3,000,000 $0.063 $189,000 Issue of options
02/12/22 Kathleen Metters Issued 3,000,000 $0.063 $189,000 Issue of options
29/11/22 Gary Phillips Issued 2,771,000 $0.063 $174,573 Issue of options
01/11/22 Gary Phillips Buy +1,640,450 $0.063 $103,348 Exercise of options
01/11/22 Gary Phillips Exercise 1,640,450 $0.063 $103,348 Exercise of options
01/11/22 Gary Phillips Transfer 1,404,950 $0.063 $88,933 Off-market transfer
01/11/22 Gary Phillips Transfer 1,404,950 $0.063 $88,933 Off-market transfer
22/08/22 Gary Phillips Expiry 1,305,700 $0.077 $100,538 Options expired
23/12/21 Gary Phillips Buy +1,638,000 $0.110 $180,180 Off-market transfer
23/12/21 Gary Phillips Transfer 1,638,000 $0.110 $180,180 Off-market transfer
22/12/21 Gary Phillips Buy +1,638,000 $0.110 $180,180 Exercise of options
22/12/21 Gary Phillips Exercise 1,638,000 $0.110 $180,180 Exercise of options
22/12/21 Malcolm McComas Issued 285,715 $0.105 $30,000 Participation in share purchase plan
22/12/21 Gary Phillips Buy +95,239 $0.105 $10,000 Participation in share purchase plan
21/12/21 Malcolm McComas Buy +1,025,000 $0.110 $112,750 On-market trade
03/11/21 Gary Phillips Issued 2,374,000 $0.115 $273,010 Issue of options
12/08/21 Gary Phillips Expiry 471,000 $0.095 $44,745 Options expired
03/05/21 Malcolm McComas Buy +500,000 $0.087 $43,500 On-market trade
04/11/20 Gary Phillips Issued 942,000 $0.110 $103,620 Issue of options
12/08/20 Gary Phillips Expiry 602,550 $0.105 $63,267 Options expired
21/11/19 Gary Phillips Issued 927,000 $0.235 $217,845 Issue of options
14/08/19 Gary Phillips Expiry 379,500 $0.205 $77,798 Options expired
22/11/18 Gary Phillips Issued 690,000 $0.255 $175,950 Issue of options
21/09/18 Gary Phillips Buy +45,154 $0.325 $14,675 Placement
21/09/18 Malcolm McComas Buy +122,568 $0.325 $39,835 Placement
21/09/18 Kathleen Metters Buy +20,000 $0.325 $6,500 Placement
21/09/18 Will Delaat Buy +20,000 $0.325 $6,500 Placement
21/09/18 Simon Buckingham Buy +44,000 $0.325 $14,300 Placement
22/06/18 Will Delaat Expiry 200,000 $0.305 $61,000 Options expired
13/11/17 Gary Phillips Transfer 2,280,000 $0.260 $592,800 Off-market transfer
13/11/17 Gary Phillips Transfer 2,280,000 $0.260 $592,800 Off-market transfer
02/12/16 Malcolm McComas Buy +200,000 $0.271 $54,167 On-market trade
29/11/16 Gary Phillips Issued 827,000 $0.275 $227,425 Issue of options
29/09/16 Gary Phillips Transfer 2,280,000 $0.272 $621,072 Off-market transfer
29/09/16 Gary Phillips Transfer 2,280,000 $0.272 $621,072 Off-market transfer
29/09/16 Gary Phillips Buy +815,000 $0.270 $220,050 Exercise of options
29/09/16 Gary Phillips Sell +400,000 $0.277 ($110,636) On-market trade
29/09/16 Gary Phillips Exercise 815,000 $0.270 $220,050 Exercise of options
20/11/15 Gary Phillips Issued 1,626,000 $0.225 $365,850 Issue of options
04/08/15 Malcolm McComas Expiry 20,000 $0.220 $4,400 Options expired
31/07/15 Gary Phillips Exercise 775,000 $0.225 $174,375 Exercise of options
31/07/15 Gary Phillips Buy +775,000 $0.225 $174,375 Exercise of options
31/07/15 Gary Phillips Expiry 717,500 $0.225 $161,438 Options expired
18/05/15 Gary Phillips Exercise 1,030,000 $0.250 $257,500 Exercise of options
18/05/15 Gary Phillips Buy +1,030,000 $0.250 $257,500 Exercise of options
26/02/15 Gary Phillips Expiry 250,000 $0.088 $22,000 Options expired

Director Interests

The current holdings of PXS directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Gary Phillips 29/11/2023 5,699,843 5,369,104 6,845,800 N/A
Waradana De Silva 30/06/2023 N/A 867,636 N/A N/A
Kathleen Metters 30/06/2023 20,000 N/A 3,000,000 N/A
Simon Green 16/12/2022 0 N/A N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 14, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Citicorp Nominees Pty Limited 147,191,348 20.38%
HSBC Custody Nominees (Australia) Limited A/C 2 108,361,494 15.01%
Hsbc Custody Nominees (Australia) Limited 73,020,165 10.11%
D and A Income Limited 38,690,477 5.36%
Lawn Views Pty Ltd <Angela Williams Family A/C> 10,350,966 1.43%
Dr Toby David Cohen 6,749,457 0.93%
Bnp Paribas Noms Pty Ltd <Drp> 6,487,405 0.90%
Healthcare Management Consulting (Australia) Pty Ltd 5,262,950 0.73%
Mr David Curzon Smith and Mrs Diane Maurine Smith <Badham Family A/C> 4,255,715 0.59%
Ms Bei Xu and Mr Dongning Wu 3,600,891 0.50%
Indcorp Consulting Group Pty Limited <Superannuation Fund A/C> 3,000,001 0.42%
Mr Xing Jiang Xue 2,729,886 0.38%
Finter Nominees Pty Ltd <TJF Family A/C> 2,700,000 0.37%
Pakasoluto Pty Limited <Barkl Family Super Fund A/C> 2,622,007 0.36%
Mr Peter John Carr 2,510,000 0.35%
BNP Paribas Nominees Pty Ltd ACF Clearstream 2,503,208 0.35%
Bunyula Super Pty Ltd <Bunyula Super Fund A/C> 2,477,076 0.34%
Mr Joseph Wallace Carson 2,476,192 0.34%
Mr Gregory Bruce Cole and Mrs Julia Theresa Cole <Greg & Julie Super Fund A/C> 2,430,000 0.34%
Mrs Sharon Lewis 2,265,715 0.31%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 351 1,071 805 1,838 560 4,625

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Biotechnology Value Fund, Inc 14/09/2023 102,778,714 14.00
Karst Peak Capital Limited 14/09/2023 87,940,615 12.00
Platinum Investment Management Limited 14/09/2023 56,488,849 8.00
D and A Income Limited 14/09/2023 84,453,719 12.00

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
09-08-23 D and A Income Limited 7,542,878 10.68 11.72
30-06-23 D and A Income Limited 7,309,534 9.68 10.68
20-03-23 Bank of America Corporation and its related bodies corporate 36,651,226 -- 5.09

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
24-07-23 Regal Funds Management Pty Ltd 38,159,163 5.30 --
29-03-23 Bank of America Corporation and its related bodies corporate 36,651,226 5.09 --
17-03-23 Regal Funds Management Pty Ltd 9,177,685 6.58 5.30
09-02-23 Regal Funds Management Pty Ltd 9,412,792 7.89 6.58

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.049 30 June
2022 $0.065 30 June
2021 $0.089 30 June
2020 $0.066 30 June
2019 $0.255 28 June
2018 $0.310 29 June
2017 $0.250 28 June
2016 $0.255 28 June
2015 $0.220 30 June
2014 $0.066 30 June
PXS Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.